 | Up a level |
Journal Article
Achilles, E. I. S., Maus, V., Fink, G. R., Maintz, D., van Eimeren, T. and Mpotsaris, A. (2016). Hemichorea with Contralateral High Signal Intensity Putaminal Lesion on T1-Weighted Images in Non-Ketotic Hyperglycemia. Forschritte Neurol. Psychiatr., 84 (4). S. 222 - 225. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3522
Baumann, A., Hartwigsen, G., Nebel, A., Wolff, S., Granert, O., Deuschl, G., Zeuner, K. and van Eimeren, T. (2015). Neural correlates of the Lee Silverman Voice Treatment in Parkinson's disease. Eur. J. Neurol., 22. S. 628 - 629. HOBOKEN: WILEY. ISSN 1468-1331
Bohn, K. P., Foerster, S., Bischof, G., Hammes, J., van Eimeren, T. and Drzezga, A. (2018). Detection of triple-pathology disease windows by means of multimodal imaging in patients with Alzheimer's disease and mild cognitive impairment with probable Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S269 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Brendel, M., Palleis, C., Prix, C., Finze, A., Boetzel, K., Danek, A., Hoellerhage, M., Beyer, L., Sauerbeck, J., Rauchmann, B., Stephens, A., Drzezga, A., van Eimeren, T., Barthel, H., Patt, M., Sabri, O., Villemagne, V., Bartenstein, P., Perneczky, R., Haass, C., Levin, J. and Hoeglinger, G. (2020). F-18-PI-2620 Tau-PET in Corticobasal Syndrome. Eur. J. Nucl. Med. Mol. Imaging, 47 (SUPPL 1). S. S93 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Doering, E., Hoenig, M. C., Bischof, G. N., Bohn, K. P., Ellingsen, L. M., van Eimeren, T. and Drzezga, A. (2022). Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment. Eur. J. Nucl. Med. Mol. Imaging, 49 (13). S. 4478 - 4490. NEW YORK: SPRINGER. ISSN 1619-7089
Hammes, J., Bischof, G., Anderl-Straub, S., Barthel, H., Beer, A. J., Danek, A., Eickhoff, S., Fassbender, K., Fliessbach, K., Landwehrmeyer, B., Lauer, M., Ludolph, A. C., Prudlo, J., Schroeter, M. L., Sabri, O., Schmidt-Diehl, J., Schneider, A., Semler, E., Wiltfang, J., Drzezga, A., Otto, M. and van Eimeren, T. (2018). Characterization of disease-specific covariance patterns of neurodegeneration in FTLD-variants. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S229 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hammes, J., Bischof, G., Fliessbach, K., Giehl, K., Jessen, F., Neumaier, B., Kukolja, J., Onur, I., Drzezga, A. and van Eimeren, T. (2016). Different binding behavior of the Tau-PET tracer [F-18]-AV-1451 in AD and Tau-positive FTLD. J. Neurochem., 138. S. 377 - 378. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159
Hammes, J., Leuwer, I., Bischof, G. N., Drzezga, A. and van Eimeren, T. (2017). Flortaucipir perfusion PET is a suitable replacement for FDG PET in patients with neurodegenerative diseases. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S250 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hoeglinger, G., Respondek, G., Stamelou, M., Kurz, C., Josephs, K., Lang, A., Mollenhauer, B., Mueller, U., Nilsson, C., Whitwell, J., Arzberger, T., Gelpi, E., Giese, A., Irwin, D., Meissner, W., Pantelyat, A., van Swieten, J., Troakes, C., Antonini, A., Bhatia, K., Bordelon, Y., Corvol, J. C., Colosimo, C., Dodel, R., Grossman, M., Kassubek, J., Krismer, F., Levin, J., Morris, H., Nestor, P., Oertel, W., Rabinovici, G., Rowe, J., van Eimeren, T., Wenning, G., Yu, J. -T., Golbe, L. I., Litvan, I. and Boxer, A. (2016). Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP). J. Neurochem., 138. S. 364 - 365. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159
Hoenig, M., Bischof, G., Kukolja, J., Onur, O., Jessen, F., Fliessbach, K., Neumaier, B., Kalbe, E., Drzezga, A. and van Eimeren, T. (2018). Effects of tau-pathology on glucose metabolism mitigated by level of education. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S102 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Kovacs, G. G., Respondek, G., van Eimeren, T., Hoeller, E., Levin, J., Mueller, U., Schwarz, S., Roesler, T. W., Schweyer, K. and Hoeglinger, G. U. (2018). Tauopathies. From molecule to therapy. Nervenarzt, 89 (10). S. 1083 - 1095. NEW YORK: SPRINGER. ISSN 1433-0407